Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 11, 2006, Pages 1264-1273

  Chan, Erin ^a   Steenland, Hendrik W ^a   Liu, Hattie ^a   Horner, Richard L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Medical Sciences Building ^*  (Canada)

Author keywords

Genioglossus muscle; Hypoglossal motor nucleus; Noradrenaline; Obstructive sleep apnea; Serotonin; Sleep

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; PHENYLEPHRINE; SEROTONIN 2 RECEPTOR; TERAZOSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HYPOGLOSSAL NUCLEUS; MALE; MUSCLE CONTRACTION; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP WAKING CYCLE; WAKEFULNESS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; HYPOGLOSSAL NERVE; MALE; MICRODIALYSIS; MOTOR NEURONS; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT2; RESPIRATORY MUSCLES; SLEEP APNEA SYNDROMES; SLEEP STAGES; SLEEP, REM; WAKEFULNESS;

EID: 33845528120     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200605-597OC     Document Type: Article

References (78)

1. Chase MH, Morales FR. Control of motoneurons during sleep. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine, 3 ed. Philadelphia, PA; WB Saunders; 2000. pp. 155-168.
2. Duron B, Marlot D. Intercostal and diaphragmatic electrical activity during wakefulness and sleep in normal unrestrained adult cats. Sleep 1980;3:269-280.
3. Sauerland EK, Harper RM. The human tongue during sleep: electromyographic activity of the genioglossus muscle. Exp Neurol 1976;51:160-170.
4. Worsnop C, Kay A, Pierce R, Kim Y, Trinder J. Activity of respiratory pump and upper airway muscles during sleep onset. J Appl Physiol 1998;85:908-920.
5. Mezzanotte WS, Tangel DJ, White DP. Influence of sleep onset on upper-airway muscle activity in apnea patients versus normal controls. Am J Respir Crit Care Med 1996;153:1880-1887.
6. Horner RL, Kozar LF, Kimoff RJ, Phillipson EA. Effects of sleep on the tonic drive to respiratory muscle and the threshold for rhythm generation in the dog. J Physiol 1994;474:525-537.
7. Orem J. Respiratory neurons and sleep. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine, 2nd ed. Philadelphia, PA; WB Saunders; 1994. pp. 177-193.
8. Phillipson EA, Bowes G. 1986. Control of breathing during sleep. In: Cherniack NS, Widdicombe , editors. Handbook of physiology, section 3: the respiratory system, vol. II, control of breathing, part 2. Bethesda, MD: American Physiological Society; 1986. pp. 649-689.
9. National Commission on Sleep Disorders Research. Wake up America: a national sleep alert. Washington, D.C.; US Government Printing Office; 1993.
10. Phillipson EA. Sleep apnea: a major public health problem. N Engl J Med 1993;328:1271-1273.
11. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
12. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978;44:931-938.
13. George CF, Nickerson PW, Hanly PJ, Millar TW, Kryger MH. Sleep apnoea patients have more automobile accidents. Lancet 1987;2:447.
14. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147-2165.
15. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997;99:106-109.
16. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-2041.
17. Jelev A, Sood S, Liu H, Nolan P, Horner RL. Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol 2001;532:467-481.
18. Parkis MA, Bayliss DA, Berger AJ. Actions of norepinephrine on rat hypoglossal motoneurons. J Neurophysiol 1995;74:1911-1919.
19. Al-Zubaidy ZA, Erickson RL, Greer JJ. Serotonergic and noradrenergic effects on respiratory neural discharge in the medullary slice preparation of neonatal rats. Pflugers Arch 1996;431:942-949.
20. Funk GD, Smith JC, Feldman JL. Development of thyrotropin-releasing hormone and norepinephrine potentiation of inspiratory-related hypoglossal motoneuron discharge in neonatal and juvenile mice in vitro. J Neurophysiol 1994;72:2538-2541.
21. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981;1:876-886.
22. Kubin L, Tojima H, Davies RO, Pack AI. Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate cat. Neurosci Lett 1992;139:243-248.
23. Chan E, Steenland HW, Liu H, Horner RL. Endogenous noradrenergic drive contributes to genioglossus muscle activation in wakefulness and non-REM sleep. Proc Am Thoracic Soc 2006;3:A316.
24. Chan E, Steenland HW, Liu H, Horner RL. Identification of an endogenous noradrenergic drive to respiratory motoneurons across sleep-wake states. Can Respir J 2006;13:165.
25. Morrison JL, Sood S, Liu H, Park E, Nolan P, Horner RL. Role of inhibitory amino acids in control of hypoglossal motor outflow to genioglossus muscle in naturally sleeping rats. J Physiol 2003;552:975-991.
26. Sood S, Morrison JL, Liu H, Horner RL. Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats. Am J Respir Crit Care Med 2005;172:1338-1347.
27. Kyncl JJ. Pharmacology of terazosin: an alpha 1-selective blocker. J Clin Pharmacol 1993;33:878-883.
28. Hancock AA, Buckner SA, Ireland LM, Knepper SM, Kerwin JF Jr. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro. J Recept Signal Transduct Res 1995;15:863-885.
29. Liu X, Sood S, Liu H, Horner RL. Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo. J Physiol 2005;565:965-980.
30. Richard CA, Harper RM. Respiratory-related activity in hypoglossal neurons across sleep-waking states in cats. Brain Res 1991;542:167-170.
31. Goh AS, Issa FG, Sullivan CE. Upper airway dilating forces during wakefulness and sleep in dogs. J Appl Physiol 1986;61:2148-2155.
32. Younes M. Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med 2003;168:645-658.
33. Aldes LD, Chapman ME, Chronister RB, Haycock JW. Sources of noradrenergic afferents to the hypoglossal nucleus in the rat. Brain Res Bull 1992;29:931-942.
34. Travers JB, Norgren R. Afferent projections to the oral motor nuclei in the rat. J Comp Neurol 1983;220:280-298.
35. Sood S, Raddatz E, Liu X, Liu H, Horner RL. Inhibition of serotonergic medullary raphe obscurus neurons suppresses genioglossus and diaphragm activities in anesthetized but not conscious rats. J Appl Physiol 2006;100:1807-1821.
36. Greer JJ, Smith JC, Feldman JL. Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. J Physiol 1991;437:727-749.
37. Funk GD, Smith JC, Feldman JL. Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids. J Neurophysiol 1993;70:1497-1515.
38. Bellingham MC, Funk GD. Cholinergic modulation of respiratory brainstem neurons and its function in sleep-wake state determination. Clin Exp Pharmacol Physiol 2000;27:132-137.
39. Steenland HW, Liu H, Sood S, Liu X, Horner RL. Respiratory activation of the genioglossus muscle involves both non-NMDA and NMDA glutamate receptors at the hypoglossal motor nucleus in-vivo. Neuroscience 2006;138:1407-1424.
40. Kuna S, Remmers JE. Anatomy and physiology of upper airway obstruction. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine, 3rd ed. Philadelphia, PA; WB Saunders. pp. 840-858.
41. Fuller DD, Williams JS, Janssen PL, Fregosi RF. Effect of co-activation of tongue protrudor and retractor muscles on tongue movements and pharyngeal airflow mechanics in the rat. J Physiol 1999;519:601-613.
42. Withington-Wray DJ, Mifflin SW, Spyer KM. Intracellular analysis of respiratory-modulated hypoglossal motoneurons in the cat. Neuroscience 1988;25:1041-1051.
43. Woch G, Kubin L. Non-reciprocal control of rhythmic activity in respiratory-modulated XII motoneurons. Neuroreport 1995;6:2085-2088.
44. Peever JH, Mateika JH, Duffin J. Respiratory control of hypoglossal motoneurones in the rat. Pflugers Arch 2001;442:78-86.
45. Tangel DJ, Mezzanotte WS, White DP. Influence of sleep on tensor palatini EMG and upper airway resistance in normal men. J Appl Physiol 1991;70:2574-2581.
46. Tangel DJ, Mezzanotte WS, Sandberg EJ, White DP. Influences of NREM sleep on the activity of tonic vs. inspiratory phasic muscles in normal men. J Appl Physiol 1992;73:1058-1066.
47. Horner RL. Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. Sleep 1996;19:827-853.
48. Pillar G, Malhotra A, Fogel RB, Beauregard J, Slamowitz DI, Shea SA, White DP. Upper airway muscle responsiveness to rising PCO(2) during NREM sleep. J Appl Physiol 2000;89:1275-1282.
49. Morrison JL, Sood S, Liu H, Park E, Nolan P, Horner RL. GABA-A receptor antagonism at the hypoglossal motor nucleus increases genioglossus muscle activity in NREM but not REM sleep. J Physiol 2003;548:569-583.
50. Fenik VB, Davies RO, Kubin L. REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs. Am J Respir Crit Care Med 2005;172:1322-1330.
51. Lai YY, Kodama T, Siegel JM. Changes in monoamine release in the ventral horn and hypoglossal nucleus linked to pontine inhibition of muscle tone: an in vivo microdialysis study. J Neurosci 2001;21:7384-7391.
52. Veasey SC. Pharmacotherapies for obstructive sleep apnea: how close are we? Curr Opin Pulm Med 2001;7:399-403.
53. Horner RL. The neuropharmacology of upper airway motor control in the awake and asleep states: implications for obstructive sleep apnoea. Respir Res 2001;2:286-294.
54. Kraiczi H, Hedner J, Dahlof P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999;22:61-67.
55. Sunderram J, Parisi RA, Strobel RJ. Serotonergic stimulation of the genioglossus and the response to nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:925-929.
56. Berry RB, Yamaura EM, Gill K, Reist C. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999;22:1087-1092.
57. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991;100:416-421.
58. Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 1999;160:1659-1667.
59. Veasey SC, Chachkes J, Fenik P, Hendricks JC. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 2001;24:155-160.
60. Aoki CR, Liu H, Downey GP, Mitchell J, Horner RL. Cyclic nucleotides modulate genioglossus and hypoglossal responses to excitatory inputs in rats. Am J Respir Crit Care Med 2006;173:555-565.
61. Soja PJ, Lopez-Rodriguez F, Morales FR, Chase MH. Effects of excitatory amino acid antagonists on the phasic depolarizing events that occur in lumbar motoneurons during REM periods of active sleep. J Neurosci 1995;15:4068-4076.
62. Rekling JC, Funk GD, Bayliss DA, Dong XW, Feldman JL. Synaptic control of motoneuronal excitability. Physiol Rev 2000;80:767-852.
63. Reiner PB. Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats. Brain Res 1986;378:86-96.
64. Aldes LD. Topographically organized projections from the nucleus subceruleus to the hypoglossal nucleus in the rat: a light and electron microscopic study with complementary axonal transport techniques. J Comp Neurol 1990;302:643-656.
65. Aston-Jones G, Shipley MT, Grzanna R. The locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G, editor. The rat nervous system. San Diego, CA: Academic Press; 1995. pp. 183-213.
66. Fenik V, Marchenko V, Janssen P, Davies RO, Kubin L. A5 cells are silenced when REM sleep-like signs are elicited by pontine carbachol. J Appl Physiol 2002;93:1448-1456.
67. Li A, Nattie E. Catecholamine neurones in rats modulate sleep, breathing, central chemoreception and breathing variability. J Physiol 2006;570:385-396.
68. Haxhiu MA, Kc P, Neziri B, Yamamoto BK, Ferguson DG, Massari VJ. Catecholaminergic microcircuitry controlling the output of airway-related vagal preganglionic neurons. J Appl Physiol 2003;94:1999-2009.
69. Haxhiu MA, Rust CF, Brooks C, Kc P. CNS determinants of sleep-related worsening of airway functions: Implications for nocturnal asthma. Respir Physiol Neurobiol 2006;151:1-30.
70. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005;172:921-929.
71. Elam M, Yao T, Thoren P, Svensson TH. Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves. Brain Res 1981;222:373-381.
72. Ballantyne D, Scheid P. Mammalian brainstem chemosensitive neurones: linking them to respiration in vitro. J Physiol 2000;525:567-577.
73. Feldman JL, Neverova NV, Saywell SA. Modulation of hypoglossal motoneuron excitability by intracellular signal transduction cascades. Respir Physiol Neurobiol 2005;147:131-143.
74. John J, Wu MF, Boehmer LN, Siegel JM. Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 2004;42:619-634.
75. Wu MF, Gulyani SA, Yau E, Mignot E, Phan B, Siegel JM. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 1999;91:1389-1399.
76. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 2002;5:1071-1075.
77. Nishino S, Fruhstorfer B, Arrigoni J, Guilleminault C, Dement WC, Mignot E. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. J Pharmacol Exp Ther 1993;264:1079-1084.
78. Guilleminault C, Anagos A. Narcolepsy. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine, 3rd ed. Philadelphia, PA: WB Saunders; 2000. pp. 676-686.